Sunday, March 16, 2025 | 05:04 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Gland Pharma rallies 8% on strong revenue growth in June quarter

Gland Pharma said the growth in revenue was contributed from a mix of launch of new products and volume growth in existing products

Lab test, research, r&d, chemicals, medical research, vaccine, health, pharma
Premium

SI Reporter Mumbai
Shares of Gland Pharma rallied 8 per cent to Rs 4,087.65 on the BSE in intra-day trade on Thursday after the company reported strong revenue growth of 31 per cent year-on-year (YoY) at Rs 1,154 crore for the quarter ended June 2021 (Q1FY22). It had posted a revenue of Rs 884 crore in the year-ago quarter.

The stock was trading at its highest level since listing on November 20, 2020. In the past one month, it has outperformed Sensex by surging nearly 30 per cent as against a  0.44 per cent gain in the index.

Gland Pharma said the growth in revenue

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in